menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Funding News

>

Emcure Pha...
source image

Bloomberg Quint

2w

read

87

img
dot

Image Credit: Bloomberg Quint

Emcure Pharma Block Deal: Public Shareholder BC Investments To Sell 2.4% Stake

  • Public shareholder BC Investments is set to sell a 2.4% stake in Emcure Pharmaceuticals Ltd. through a block deal at an offer price of Rs 1,225 per share, representing a 4% discount on the current market price.
  • The offer size for the stake sale is Rs 551 crore, with Kotak Securities acting as the book runners for the deal.
  • Emcure Pharmaceuticals' stock closed 0.72% higher at Rs 1,279.8 per share, reporting a 26.96% increase in the last 12 months and an 11.56% decrease year-to-date.
  • Analysts tracking the company suggest a potential downside of 13.9% according to the average of 12-month price targets, with a mix of 'buy' and 'hold' recommendations for the stock.

Read Full Article

like

5 Likes

For uninterrupted reading, download the app